Equities

abrdn World Healthcare Fund

  • Add to watchlist
  • Add to portfolio
  • Add an alert
THW:NYQ

abrdn World Healthcare Fund

Actions
FinancialsClosed End Investments
  • Price (USD)12.73
  • Today's Change0.08 / 0.63%
  • Shares traded163.12k
  • 1 Year change+7.25%
  • Beta0.7555
Data delayed at least 15 minutes, as of Feb 17 2026 20:59 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year abrdn World Healthcare Fund's revenues fell -12.83% from 12.67m to 11.04m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 93.36m to 55.39m, a -40.67% decrease.
Gross margin-16.86%
Net profit margin501.55%
Operating margin-21.72%
Return on assets8.85%
Return on equity11.04%
Return on investment8.90%
More ▼

Cash flow in USDView more

In 2025, abrdn World Healthcare Fund increased its cash reserves by 195,188.00%, or 487.97k. The company earned 34.13m from its operations for a Cash Flow Margin of 309.05%. In addition the company used on investing activities and also paid 33.64m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share12.71
Tangible book value per share12.71
More ▼

Balance sheet in USDView more

abrdn World Healthcare Fund has a Debt to Total Capital ratio of 18.97%, a lower figure than the previous year's 24.43%.
Current ratio--
Quick ratio--
Total debt/total equity0.2341
Total debt/total capital0.1897
More ▼

Growth rates in USD

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -43.40%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)10.24%
Div growth rate (5 year)0.00%
Payout ratio (TTM)100.29%
EPS growth(5 years)-7.41
EPS (TTM) vs
TTM 1 year ago
-44.97
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.